Since FABP4 plays a critical role in coordinating cellular metabolism and inflammatory responses, numerous efforts have been taken to develop FABP4 inhibitors to treat immunometabolic diseases such as obesity, diabetes, and atherosclerosis. Here, FABP4 is linked to obesity disorder.